The neuropeptide substance P creates a contrast-enhancing pattern in striatal dopamine signaling — boosting it in one brain compartment while suppressing it at borders, resolving a decades-long contradiction.
BidirectionalSubstance P boosts dopamine in striosome centers but suppresses it at striosome-matrix borders, creating a spatial contrast pattern
What the researchers found
Substance P, a neuropeptide concentrated in specific brain compartments called striosomes, has opposite effects on dopamine release depending on exactly where in the striatum you look. In the center of striosomes, substance P boosted dopamine release. At striosome-matrix borders, it suppressed dopamine. In the surrounding matrix, it had no effect.
This bidirectional modulation creates a "center-surround contrast" pattern — substance P sharpens the dopamine signal by enhancing it in one location while suppressing it nearby. The effects were mediated through neurokinin-1 (NK1) receptors. This resolves a long-standing contradiction in the literature, where different studies reported substance P either increasing or decreasing dopamine, depending on where they happened to record.
Why it matters
The striatum is the brain's action selection and reward center, and dopamine is its primary currency. Understanding how neuropeptides like substance P fine-tune dopamine signals within the striatum's microarchitecture is essential for understanding disorders like Parkinson's disease, addiction, and compulsive behavior. The discovery that substance P creates a spatial contrast pattern for dopamine suggests it plays a role in sharpening the brain's ability to select between competing actions or rewards.
The numbers in context
Bidirectional effects · boosted in striosome centers · suppressed at borders · no effect in matrix · mediated via NK1 receptors · resolved conflicting prior findings
How the study worked
The researchers measured evoked dopamine release using carbon-fiber microelectrodes in mouse brain slices (ex vivo). After recording dopamine responses in the presence and absence of substance P, they identified the exact anatomical location of each recording site relative to μ-opioid receptor-rich striosomes using immunohistochemistry. This allowed them to correlate substance P's effects with precise compartmental location within the striatum.
Who was studied
C57BL/6 mouse striatal brain slices
What this study cannot tell us
Ex vivo brain slice recordings capture local effects but may not fully represent the dynamic interactions that occur in the intact brain. The study used mouse tissue, and striatal compartmentalization may differ in humans. Only acute substance P application was tested — chronic or pulsatile neuropeptide release patterns in vivo may produce different effects. The functional consequences of substance P-mediated contrast sharpening for behavior were not tested.
How to read the evidence
Published in the Journal of Neuroscience, this study uses precise ex vivo electrochemistry paired with post-hoc anatomical identification — a technically demanding and rigorous approach. The 'Strong' grade reflects the methodological rigor and the clean resolution of a previously conflicting literature.
When this study was published
Published in 2015, this study provided a key insight into striatal compartmentalization that has influenced subsequent research on basal ganglia function. The findings remain current and frequently cited.
The bigger picture
Neuropeptides like substance P add a layer of spatial precision to neurotransmitter signaling that classical neuroscience has only recently begun to appreciate. This study demonstrates that the striatum's compartmental architecture (striosomes vs. matrix) isn't just anatomical curiosity — it's functionally meaningful for how dopamine signals are processed. This has implications for understanding Parkinson's disease (where striosomal neurons are preferentially lost early) and addiction (where dopamine signaling goes awry).
Questions still open
- Does the loss of substance P-mediated dopamine contrast contribute to the motor symptoms of Parkinson's disease?
- Could NK1 receptor antagonists (which are already available as drugs) be used to modulate dopamine signaling in addiction?
- Does this center-surround pattern change in addictive states where dopamine signaling is chronically altered?
Common questions
What are striosomes and why do they matter?
Why did scientists previously disagree about substance P's effect on dopamine?
Read the original research
Substance P Weights Striatal Dopamine Transmission Differently within the Striosome-Matrix Axis.
The Journal of neuroscience : the official journal of the Society for Neuroscience, 35(24), 9017-23
Citation
Brimblecombe, Katherine R; Cragg, Stephanie J. (2015). Substance P Weights Striatal Dopamine Transmission Differently within the Striosome-Matrix Axis.. The Journal of neuroscience : the official journal of the Society for Neuroscience, 35(24), 9017-23. https://doi.org/10.1523/JNEUROSCI.0870-15.2015